• This topic is empty.
Viewing 0 reply threads
  • Author
    • #22715

      Anticipation is growing as Roche/Genentech’s treatment risdiplam, the first oral medication to treat SMA, is under FDA review.

      Also, SMA News Today’s multimedia associate, Price Wooldridge, discusses how the lack of SMA protein may also directly contribute to SMA.

      Are you interested in learning more about spinal muscular atrophy? If so, please visit smanewstoday.com/

      What are your thoughts on this news? Let us know about it in the comment section below.
Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account